Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension

Christopher Austin, Khadija Alassas, Charles Dwayne Burger, Robert Safford, Ricardo Pagan, Katherine Duello, Preetham Kumar, Tonya Zeiger, Brian P Shapiro

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Elevated mean right atrial pressure (RAP) measured by cardiac catheterization is an independent risk factor for mortality. Prior studies have demonstrated a modest correlation with invasive and noninvasive echocardiographic RAP, but the prognostic impact of estimated right atrial pressure (eRAP) has not been previously evaluated in patients with pulmonary arterial hypertension (PAH). Methods: A retrospective analysis of 121 consecutive patients with PAH based on right-sided heart catheterization and echocardiography was performed. The eRAP was calculated by inferior vena cava diameter and collapse using 2005 and 2010 American Society of Echocardiography (ASE) definitions. Accuracy and correlation of eRAP to RAP was assessed. Kaplan-Meier survival analysis by eRAP, right atrial area, and Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) risk criteria as well as univariate and multivariate analysis of echocardiographic findings was performed. Results: Elevation of eRAP was associated with decreased survival time compared with lower eRAP (P < .001, relative risk = 7.94 for eRAP > 15 mm Hg vs eRAP ≤ 5 mm Hg). Univariate analysis of echocardiographic parameters including eRAP > 15 mm Hg, right atrial area > 18 cm2, presence of pericardial effusion, right ventricular fractional area change < 35%, and at least moderate tricuspid regurgitation was predictive of poor survival. However, multivariate analysis revealed that eRAP > 15 mm Hg was the only echocardiographic risk factor that was predictive of mortality (hazard ratio = 2.28, P = .037). Conclusions: Elevation of eRAP by echocardiography at baseline assessment was strongly associated with increased risk of death or transplant in patients with PAH. This measurement may represent an important prognostic component in the comprehensive echocardiographic evaluation of PAH.

Original languageEnglish (US)
Pages (from-to)198-208
Number of pages11
JournalChest
Volume147
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Atrial Pressure
Pulmonary Hypertension
Mortality
Cardiac Catheterization
Registries
Echocardiography
Pericardial Effusion
Kaplan-Meier Estimate
Inferior Vena Cava
Survival Analysis
Disease Management
Multivariate Analysis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension. / Austin, Christopher; Alassas, Khadija; Burger, Charles Dwayne; Safford, Robert; Pagan, Ricardo; Duello, Katherine; Kumar, Preetham; Zeiger, Tonya; Shapiro, Brian P.

In: Chest, Vol. 147, No. 1, 01.01.2015, p. 198-208.

Research output: Contribution to journalArticle

Austin, Christopher ; Alassas, Khadija ; Burger, Charles Dwayne ; Safford, Robert ; Pagan, Ricardo ; Duello, Katherine ; Kumar, Preetham ; Zeiger, Tonya ; Shapiro, Brian P. / Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension. In: Chest. 2015 ; Vol. 147, No. 1. pp. 198-208.
@article{b2c7f9cf34d94ba384832daef107d3ca,
title = "Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension",
abstract = "Background: Elevated mean right atrial pressure (RAP) measured by cardiac catheterization is an independent risk factor for mortality. Prior studies have demonstrated a modest correlation with invasive and noninvasive echocardiographic RAP, but the prognostic impact of estimated right atrial pressure (eRAP) has not been previously evaluated in patients with pulmonary arterial hypertension (PAH). Methods: A retrospective analysis of 121 consecutive patients with PAH based on right-sided heart catheterization and echocardiography was performed. The eRAP was calculated by inferior vena cava diameter and collapse using 2005 and 2010 American Society of Echocardiography (ASE) definitions. Accuracy and correlation of eRAP to RAP was assessed. Kaplan-Meier survival analysis by eRAP, right atrial area, and Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) risk criteria as well as univariate and multivariate analysis of echocardiographic findings was performed. Results: Elevation of eRAP was associated with decreased survival time compared with lower eRAP (P < .001, relative risk = 7.94 for eRAP > 15 mm Hg vs eRAP ≤ 5 mm Hg). Univariate analysis of echocardiographic parameters including eRAP > 15 mm Hg, right atrial area > 18 cm2, presence of pericardial effusion, right ventricular fractional area change < 35{\%}, and at least moderate tricuspid regurgitation was predictive of poor survival. However, multivariate analysis revealed that eRAP > 15 mm Hg was the only echocardiographic risk factor that was predictive of mortality (hazard ratio = 2.28, P = .037). Conclusions: Elevation of eRAP by echocardiography at baseline assessment was strongly associated with increased risk of death or transplant in patients with PAH. This measurement may represent an important prognostic component in the comprehensive echocardiographic evaluation of PAH.",
author = "Christopher Austin and Khadija Alassas and Burger, {Charles Dwayne} and Robert Safford and Ricardo Pagan and Katherine Duello and Preetham Kumar and Tonya Zeiger and Shapiro, {Brian P}",
year = "2015",
month = "1",
day = "1",
doi = "10.1378/chest.13-3035",
language = "English (US)",
volume = "147",
pages = "198--208",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension

AU - Austin, Christopher

AU - Alassas, Khadija

AU - Burger, Charles Dwayne

AU - Safford, Robert

AU - Pagan, Ricardo

AU - Duello, Katherine

AU - Kumar, Preetham

AU - Zeiger, Tonya

AU - Shapiro, Brian P

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Elevated mean right atrial pressure (RAP) measured by cardiac catheterization is an independent risk factor for mortality. Prior studies have demonstrated a modest correlation with invasive and noninvasive echocardiographic RAP, but the prognostic impact of estimated right atrial pressure (eRAP) has not been previously evaluated in patients with pulmonary arterial hypertension (PAH). Methods: A retrospective analysis of 121 consecutive patients with PAH based on right-sided heart catheterization and echocardiography was performed. The eRAP was calculated by inferior vena cava diameter and collapse using 2005 and 2010 American Society of Echocardiography (ASE) definitions. Accuracy and correlation of eRAP to RAP was assessed. Kaplan-Meier survival analysis by eRAP, right atrial area, and Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) risk criteria as well as univariate and multivariate analysis of echocardiographic findings was performed. Results: Elevation of eRAP was associated with decreased survival time compared with lower eRAP (P < .001, relative risk = 7.94 for eRAP > 15 mm Hg vs eRAP ≤ 5 mm Hg). Univariate analysis of echocardiographic parameters including eRAP > 15 mm Hg, right atrial area > 18 cm2, presence of pericardial effusion, right ventricular fractional area change < 35%, and at least moderate tricuspid regurgitation was predictive of poor survival. However, multivariate analysis revealed that eRAP > 15 mm Hg was the only echocardiographic risk factor that was predictive of mortality (hazard ratio = 2.28, P = .037). Conclusions: Elevation of eRAP by echocardiography at baseline assessment was strongly associated with increased risk of death or transplant in patients with PAH. This measurement may represent an important prognostic component in the comprehensive echocardiographic evaluation of PAH.

AB - Background: Elevated mean right atrial pressure (RAP) measured by cardiac catheterization is an independent risk factor for mortality. Prior studies have demonstrated a modest correlation with invasive and noninvasive echocardiographic RAP, but the prognostic impact of estimated right atrial pressure (eRAP) has not been previously evaluated in patients with pulmonary arterial hypertension (PAH). Methods: A retrospective analysis of 121 consecutive patients with PAH based on right-sided heart catheterization and echocardiography was performed. The eRAP was calculated by inferior vena cava diameter and collapse using 2005 and 2010 American Society of Echocardiography (ASE) definitions. Accuracy and correlation of eRAP to RAP was assessed. Kaplan-Meier survival analysis by eRAP, right atrial area, and Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) risk criteria as well as univariate and multivariate analysis of echocardiographic findings was performed. Results: Elevation of eRAP was associated with decreased survival time compared with lower eRAP (P < .001, relative risk = 7.94 for eRAP > 15 mm Hg vs eRAP ≤ 5 mm Hg). Univariate analysis of echocardiographic parameters including eRAP > 15 mm Hg, right atrial area > 18 cm2, presence of pericardial effusion, right ventricular fractional area change < 35%, and at least moderate tricuspid regurgitation was predictive of poor survival. However, multivariate analysis revealed that eRAP > 15 mm Hg was the only echocardiographic risk factor that was predictive of mortality (hazard ratio = 2.28, P = .037). Conclusions: Elevation of eRAP by echocardiography at baseline assessment was strongly associated with increased risk of death or transplant in patients with PAH. This measurement may represent an important prognostic component in the comprehensive echocardiographic evaluation of PAH.

UR - http://www.scopus.com/inward/record.url?scp=84920736366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920736366&partnerID=8YFLogxK

U2 - 10.1378/chest.13-3035

DO - 10.1378/chest.13-3035

M3 - Article

C2 - 25211049

AN - SCOPUS:84920736366

VL - 147

SP - 198

EP - 208

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -